4.30
price down icon1.60%   -0.07
after-market 시간 외 거래: 4.33 0.03 +0.70%
loading
전일 마감가:
$4.37
열려 있는:
$4.29
하루 거래량:
957.07K
Relative Volume:
0.68
시가총액:
$521.43M
수익:
-
순이익/손실:
$-242.30M
주가수익비율:
-1.7339
EPS:
-2.48
순현금흐름:
$-192.10M
1주 성능:
-6.11%
1개월 성능:
-39.94%
6개월 성능:
-63.74%
1년 성능:
-35.92%
1일 변동 폭
Value
$4.20
$4.43
1주일 범위
Value
$4.115
$5.09
52주 변동 폭
Value
$3.72
$12.61

코젠트 바이오사이언시스 Stock (COGT) Company Profile

Name
명칭
Cogent Biosciences Inc
Name
전화
617-945-5576
Name
주소
275 WYMAN STREET, WALTHAM
Name
직원
205
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
COGT's Discussions on Twitter

COGT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
COGT
Cogent Biosciences Inc
4.30 521.43M 0 -242.30M -192.10M -2.48
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

코젠트 바이오사이언시스 Stock (COGT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-07 개시 Scotiabank Sector Outperform
2024-12-11 다운그레이드 Needham Buy → Hold
2024-02-26 다운그레이드 Robert W. Baird Outperform → Neutral
2024-02-08 개시 Citigroup Buy
2023-12-11 다운그레이드 Wedbush Outperform → Neutral
2023-12-08 개시 JP Morgan Overweight
2023-04-28 개시 Robert W. Baird Outperform
2023-03-27 재개 H.C. Wainwright Buy
2022-12-14 개시 Needham Buy
2022-06-28 개시 Guggenheim Buy
2021-10-11 개시 H.C. Wainwright Buy
2021-06-09 재개 Jefferies Buy
2020-12-23 개시 Piper Sandler Overweight
2020-10-14 개시 Ladenburg Thalmann Buy
모두보기

코젠트 바이오사이언시스 주식(COGT)의 최신 뉴스

pulisher
11:30 AM

Cogent Biosciences Inc (COGT) Becoming More Attractive for Investors - knoxdaily.com

11:30 AM
pulisher
Apr 20, 2025

(COGT) Technical Data - news.stocktradersdaily.com

Apr 20, 2025
pulisher
Apr 20, 2025

Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts - Insider Monkey

Apr 20, 2025
pulisher
Apr 20, 2025

Geode Capital Management LLC Boosts Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Apr 20, 2025
pulisher
Apr 16, 2025

Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 16, 2025
pulisher
Apr 15, 2025

Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight - GlobeNewswire Inc.

Apr 15, 2025
pulisher
Apr 13, 2025

Vanguard Group Inc. Purchases 418,975 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Wellington Management Group LLP Trims Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

KLP Kapitalforvaltning AS Takes $88,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Corebridge Financial Inc. - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Cogent: Several 2025 Readouts On Deck With Bezuclastinib Advancement - Seeking Alpha

Apr 09, 2025
pulisher
Apr 08, 2025

Cogent Biosciences stock hits 52-week low at $4.24 By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Cogent Biosciences stock hits 52-week low at $4.24 - Investing.com

Apr 08, 2025
pulisher
Apr 04, 2025

Trend Tracker for (COGT) - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Apr 03, 2025

Teacher Retirement System of Texas Grows Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus PT from Brokerages - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

When Would Be The Best Time To Buy Cogent Biosciences Inc (NASDAQ: COGT) Stock? - stocksregister.com

Mar 31, 2025
pulisher
Mar 31, 2025

21,653 Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) Bought by Quantbot Technologies LP - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Swiss National Bank Sells 3,000 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

We're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn Rate - Yahoo

Mar 29, 2025
pulisher
Mar 29, 2025

Proficio Capital Partners LLC Buys New Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Mar 29, 2025
pulisher
Mar 26, 2025

Cogent Biosciences Announces Multiple Poster Presentations - GlobeNewswire

Mar 26, 2025
pulisher
Mar 25, 2025

Cogent Biosciences Announces Multiple Poster Presentations At 2025 American Association For Cancer Research (AACR) Annual Meeting - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Cogent's Cancer Breakthrough: 4 Precision Therapies Target KRAS, HER2, and Drug Resistance - StockTitan

Mar 25, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Boosts Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Mar 25, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Has $2.02 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Is Cogent Biosciences (COGT) Stock A Solid Choice Right Now? - Barchart

Mar 20, 2025
pulisher
Mar 20, 2025

Is Cogent Biosciences (COGT) Stock a Solid Choice Right Now? - TradingView

Mar 20, 2025
pulisher
Mar 18, 2025

Cogent Biosciences (COGT): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Mar 18, 2025
pulisher
Mar 17, 2025

Is Cogent Biosciences, Inc. (COGT) a Best Biotech Stock According to Billionaires? - Insider Monkey

Mar 17, 2025
pulisher
Mar 14, 2025

Proficio Capital Partners LLC Invests $93,000 in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Mar 14, 2025
pulisher
Mar 11, 2025

Gastrointestinal Stromal Tumor Treatment Market Size Report - openPR

Mar 11, 2025
pulisher
Mar 10, 2025

Cogent Biosciences (NASDAQ:COGT) Earns Sector Outperform Rating from Analysts at Scotiabank - Armenian Reporter

Mar 10, 2025
pulisher
Mar 09, 2025

Scotiabank Begins Coverage on Cogent Biosciences (NASDAQ:COGT) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Scotiabank Initiates Coverage of Cogent Biosciences (COGT) with Sector Outperform Recommendation - Nasdaq

Mar 08, 2025
pulisher
Mar 08, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.00 Average Target Price from Brokerages - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Cogent Biosciences Announces Participation in the Leerink Healthcare Conference - The Manila Times

Mar 07, 2025
pulisher
Mar 07, 2025

Cogent Biosciences initiated with an Outperform at Scotiabank - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

New York State Common Retirement Fund Has $180,000 Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

When the Price of (COGT) Talks, People Listen - Stock Traders Daily

Mar 03, 2025
pulisher
Feb 28, 2025

Buy Rating for Cogent Biosciences Backed by Promising Clinical Trial Results and Market Potential - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Q1 EPS Forecast for Cogent Biosciences Increased by Analyst - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

Wedbush Equities Analysts Lift Earnings Estimates for COGT - The AM Reporter

Feb 28, 2025
pulisher
Feb 28, 2025

Needham & Company LLC Reiterates Hold Rating for Cogent Biosciences (NASDAQ:COGT) - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

Cogent Biosciences Reports 2024 Financial Results and Clinical Progress - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Cogent Biosciences: Promising Pipeline and Financial Stability Drive Buy Rating - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cogent Biosciences Announces SUMMIT Continues to Showcase - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Cogent Biosciences Reports 65% Improvement In Symptom Score From Bezuclastinib In NonAdvSM - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

Cogent Biosciences announces expanded results from OLE portion of SUMMIT trial - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients - Yahoo Canada Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Wedbush Reaffirms “Neutral” Rating for Cogent Biosciences (NASDAQ:COGT) - Defense World

Feb 27, 2025

코젠트 바이오사이언시스 (COGT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):